James A. Magner

3.3k total citations · 1 hit paper
63 papers, 2.2k citations indexed

About

James A. Magner is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cell Biology. According to data from OpenAlex, James A. Magner has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Endocrinology, Diabetes and Metabolism, 28 papers in Molecular Biology and 9 papers in Cell Biology. Recurrent topics in James A. Magner's work include Thyroid Disorders and Treatments (31 papers), Glycosylation and Glycoproteins Research (20 papers) and Growth Hormone and Insulin-like Growth Factors (20 papers). James A. Magner is often cited by papers focused on Thyroid Disorders and Treatments (31 papers), Glycosylation and Glycoproteins Research (20 papers) and Growth Hormone and Insulin-like Growth Factors (20 papers). James A. Magner collaborates with scholars based in United States, Canada and Australia. James A. Magner's co-authors include James D. Brierley, Steven I. Sherman, Bryan R. Haugen, Kenneth B. Ain, David S. Cooper, Douglas S. Ross, Harry R. Maxon, Paul W. Ladenson, Jacqueline Jonklaas and Monica C. Skarulis and has published in prestigious journals such as Journal of Biological Chemistry, Endocrine Reviews and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

James A. Magner

60 papers receiving 2.2k citations

Hit Papers

Outcomes of Patients with Differentiated Thyroid Carcinom... 2006 2026 2012 2019 2006 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy
    2006 507 citations Jacqueline Jonklaas, Kenneth B. Ain et al. Thyroid profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A. Magner United States 23 1.8k 616 500 315 245 63 2.2k
Nicholas A. Romas United States 24 776 0.4× 228 0.4× 462 0.9× 322 1.0× 284 1.2× 69 1.9k
William D. Drucker United States 18 973 0.5× 321 0.5× 301 0.6× 221 0.7× 174 0.7× 32 1.5k
Juanita A. Archer United States 11 546 0.3× 559 0.9× 804 1.6× 337 1.1× 162 0.7× 16 1.8k
Carol M. Wilson United States 25 842 0.5× 180 0.3× 1.1k 2.1× 738 2.3× 137 0.6× 58 2.3k
J Mahoudeau France 19 1.1k 0.6× 446 0.7× 319 0.6× 228 0.7× 324 1.3× 42 1.6k
Daniel U. Rabin United States 19 667 0.4× 706 1.1× 540 1.1× 673 2.1× 81 0.3× 36 1.6k
M Kaplan United States 19 672 0.4× 267 0.4× 280 0.6× 144 0.5× 28 0.1× 31 1.5k
Najib Lamharzi United States 17 427 0.2× 113 0.2× 391 0.8× 187 0.6× 139 0.6× 20 1.1k
Rachel M. Williams United Kingdom 21 511 0.3× 356 0.6× 988 2.0× 437 1.4× 233 1.0× 53 1.8k
Kin‐Chuen Leung Australia 20 976 0.5× 146 0.2× 398 0.8× 321 1.0× 87 0.4× 31 1.5k

Countries citing papers authored by James A. Magner

Since Specialization
Citations

This map shows the geographic impact of James A. Magner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Magner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Magner more than expected).

Fields of papers citing papers by James A. Magner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Magner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Magner. The network helps show where James A. Magner may publish in the future.

Co-authorship network of co-authors of James A. Magner

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Magner. A scholar is included among the top collaborators of James A. Magner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Magner. James A. Magner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pearce, Elizabeth N., Stephanie L. Lee, Richard V. Weiss, et al.. (2016). Unique obstacles to establishing thyroid cancer registries. Journal of Clinical & Translational Endocrinology. 3. 12–13. 1 indexed citations
2.
Magner, James A.. (2014). Historical Note: Many Steps Led to the Discovery' of Thyroid-Stimulating Hormone. European Thyroid Journal. 3(2). 95–100. 9 indexed citations
3.
McLeod, Donald S.A., David S. Cooper, Paul W. Ladenson, et al.. (2013). Prognosis of Differentiated Thyroid Cancer in Relation to Serum Thyrotropin and Thyroglobulin Antibody Status at Time of Diagnosis. Thyroid. 24(1). 35–42. 103 indexed citations
4.
Bartenstein, Peter, C.L. Maini, Renzo Mazzarotto, et al.. (2013). High-Risk Patients with Differentiated Thyroid Cancer T4 Primary Tumors Achieve Remnant Ablation Equally Well Using rhTSH or Thyroid Hormone Withdrawal. Thyroid. 24(3). 480–487. 23 indexed citations
5.
Braverman, Lewis E., et al.. (2008). Evaluation Of Various Doses Of Recombinant Human Thyrotropin In Patients With Multinodular Goiters. Endocrine Practice. 14(7). 832–839. 17 indexed citations
6.
Magner, James A., et al.. (1997). Transiently Decreased Sialylation of Thyrotropin (TSH) in a Patient with the Euthyroid Sick Syndrome. Thyroid. 7(1). 55–61. 11 indexed citations
7.
Latham, J., et al.. (1997). Duodenal Obstruction in Thyroid Storm. Southern Medical Journal. 90(11). 1143–1146. 14 indexed citations
8.
Magner, James A. & David K. Snyder. (1994). Methimazole-Induced Agranulocytosis Treated with Recombinant Human Granulocyte Colony-Stimulating Factor (G-CSF). Thyroid. 4(3). 295–296. 13 indexed citations
9.
Harel, Guershon, et al.. (1993). Effect of Thyroid Hormone Deficiency on Glycosylation of Rat TSH SecretedIn Vitro. Hormone and Metabolic Research. 25(5). 278–280. 6 indexed citations
10.
11.
Magner, James A., Anne Klibanski, Henry G. Fein, et al.. (1992). Ricin and lentil lectin-affinity chromatography reveals oligosaccharide heterogeneity of thyrotropin secreted by 12 human pituitary tumors. Metabolism. 41(9). 1009–1015. 22 indexed citations
12.
13.
Miura, Yoshitaka, et al.. (1989). Brefeldin A Inhibits Oligosaccharide Processing of Glycoproteins in Mouse Hypothyroid Pituitary Tissue at Several Subcellular Sites. Experimental Biology and Medicine. 190(3). 286–293. 16 indexed citations
14.
Magner, James A.. (1989). Assay of sulfotransferase in subcellular fractions of hypothyroid mouse pituitary and liver tissue. Biochemical Medicine and Metabolic Biology. 41(1). 81–83. 1 indexed citations
15.
16.
Miura, Yoshitaka, et al.. (1988). Differential Susceptibility toN-Glycanase at the Individual Glycosylation Sites of Mouse Thyrotropin and Free α-Subunits*. Endocrinology. 123(5). 2207–2213. 5 indexed citations
17.
18.
19.
Magner, James A., et al.. (1988). Congestive heart failure and sudden death in a young woman with thyrotoxicosis.. PubMed. 149(1). 86–91. 29 indexed citations
20.
Lemon, Lee T., et al.. (1972). Jewish Ceremonial Art and Religious Observance. Journal of Aesthetics and Art Criticism. 30(4). 569–569. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas A. Romas Breakdown of academic impact, for papers by William D. Drucker Breakdown of academic impact, for papers by Juanita A. Archer Breakdown of academic impact, for papers by Carol M. Wilson Breakdown of academic impact, for papers by J Mahoudeau Breakdown of academic impact, for papers by Daniel U. Rabin Breakdown of academic impact, for papers by M Kaplan Breakdown of academic impact, for papers by Najib Lamharzi Breakdown of academic impact, for papers by Rachel M. Williams Breakdown of academic impact, for papers by Kin‐Chuen Leung
Rankless by CCL
2026